Topics

Biohaven's Rimegepant for Migraines Heads to the FDA for Approval Following Successful Trial http://dlvr.it/R8F6sj pic.twitter.com/5ZOIamWxIz

16:58 EDT 11 Jul 2019 | Biotechnology Twitter

Biohaven's Rimegepant for Migraines Heads to the FDA for Approval Following Successful Trial http://dlvr.it/R8F6sj 

Original Article: Biohaven's Rimegepant for Migraines Heads to the FDA for Approval Following Successful Trial http://dlvr.it/R8F6sj pic.twitter.com/5ZOIamWxIz

NEXT ARTICLE

More From BioPortfolio on "Biohaven's Rimegepant for Migraines Heads to the FDA for Approval Following Successful Trial http://dlvr.it/R8F6sj pic.twitter.com/5ZOIamWxIz"

Quick Search